Exane Derivatives’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-27,776
| Closed | -$83.3K | – | 983 |
|
|
2022
Q1 | $83.3K | Buy |
+27,776
| New | +$83.3K | 0.02% | 492 |
|
|
2021
Q4 | – | Sell |
-30,145
| Closed | -$189K | – | 1022 |
|
|
2021
Q3 | $189K | Buy |
30,145
+6,172
| +26% | +$38.8K | 0.05% | 393 |
|
|
2021
Q2 | $141K | Sell |
23,973
-21,109
| -47% | -$124K | 0.03% | 485 |
|
|
2021
Q1 | $285K | Sell |
45,082
-6,202
| -12% | -$39.2K | 0.08% | 224 |
|
|
2020
Q4 | $289K | Buy |
51,284
+6,407
| +14% | +$36.1K | 0.08% | 247 |
|
|
2020
Q3 | $261K | Buy |
44,877
+1,004
| +2% | +$5.84K | 0.08% | 174 |
|
|
2020
Q2 | $316K | Sell |
43,873
-9,301
| -17% | -$67.1K | 0.08% | 174 |
|
|
2020
Q1 | $249K | Buy |
+53,174
| New | +$249K | 0.07% | 163 |
|